Companion Animal Ear Infection Treatment Market is Segmented By Disease Type(Otitis Externa, Otitis Media, Otitis Interna), By Animal Type(Dogs, Cats, Others), By Mode of Administration(Oral, Topical, Otic), By Drug Class(Anti-bacterial, Anti-fungal, Corticosteroids, Others), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview
The Companion Animal Ear Infection Treatment Market is growing at a high CAGR during the forecast period (2024-2031).
An ear infection, also known as otitis media or otitis externa, is an inflammation of the outer, middle, or inner ear canal. The most common site of otitis in an animal is the outer ear, which can deteriorate and spread to the middle ear. Inflammation in the middle ear canal can spread to the inner ear. Ear infections in animals usually result in reddish ears that are painful to touch and exude a foul-smelling substance. A ruptured eardrum is a common complication of a middle ear infection. More severe cases of otitis can result in a partial hearing, loss of balance, nausea and vomiting, and visual nerve difficulties. When it comes to killing yeast, germs, and mites, topical treatments inserted into the ear canal are often highly effective. To help fight germs, yeast, and mites, oral drugs are used with other therapies.
As per DataM Intelligence, Companion Animal Ear Infection Treatment Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Companion Animal Ear Infection Treatment Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.
Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Companion Animal Ear Infection Treatment Market in the United States and Canada produces the utmost share. Whereas the European Companion Animal Ear Infection Treatment Market is projected to continue its presence globally during the period of 2024-2031.
Market Summary
| Metrics | Details |
| Market CAGR | High |
| Segments Covered | By Disease Type, By Animal Type, By Mode of Administration, By Drug Class, By Distribution Channel, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For more details on this report – Request for Sample
Market Dynamics
Innovative therapies in the clinical trials for otitis externa are expected to drive market growth.
The LED-Illuminated Gel (LIG) appears to be useful in relieving clinical conditions, regulating inflammation, and controlling microorganisms in dogs with otitis externa. It may aid in minimizing or avoiding antibiotic treatment in cases of otitis due to its similar efficacy to SOC. In addition, the lesser frequency of LIG treatment compared to the standard of care may improve therapeutic compliance. Furthermore, Osurnia is a novel, easy-to-use drug for treating ear infections (otitis). In just two weeks, it provides relief to the dog with two simple treatments. Treatments are performed at a veterinary facility, eliminating the need for unpleasant ear cleaning or home treatment. Thus, from the above statements, the market is expected to drive in the forecast period.
Restraint:
Side effects of drugs and lack of care, whereas aggressive pets and lack of professionalism are factors the market is expected to hamper in the forecast period.
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. Otitis externa in pets is becoming more common, one of the market's major development factors. The disease has largely affected canine pets, which has fueled industry growth. Due to the rigorous lockdown imposed during COVID-19, veterinary clinic activities were constrained, decreasing veterinarian visits. This has had a significant influence on the worldwide market's overall development. However, since the steady recovery from the COVID-19 epidemic, the market has demonstrated a V-shaped growth trajectory.
Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.
Market Segment Analysis
Otitis Externa segment is expected to hold the largest market share in companion animal ear infection treatment market
The otitis externa segment is expected to dominate in 2021. Otitis externa is an infection of the ear canal epithelium (lining) and adjacent structures, leading to secondary bacterial colonization. It may be linked to various dermatological conditions such as allergy or immune-mediated skin disease and systemic illnesses. It is usually treated; however, it can become chronic in certain situations, necessitating surgical intervention and, in rare cases, leading to deformity and fatal complications. According to several studies, when pedigreed dogs are divided into two groups based on whether they have pendulous or upright ears, otitis externa is between 13 and 14 percent and 5 percent, respectively.
Moreover, otitis externa is most strongly related to certain breeds within each group (whether ears are hanging or upright) and is most common in Cocker Spaniels, Poodles, and German Shepherd Dogs. It's been believed that a dangling ear or an abundance of hair in the ear canal increases humidity, which could encourage the spread of infection caused by a skin condition or irritant. Therefore, it has increased the demand for the treatment. Thus, the market segment is expected to hold the largest market share in the forecast period from the above statements.
Market Geographical Share
North America region holds the largest market share in the global companion animal ear infection treatment market
In 2021, North America accounted for the highest revenue share. The growth in the number of veterinarians and veterinary clinics, the existence of major animal health companies, the introduction of veterinary health information systems have enabled real-time diagnosis in the region and the investment in R&D to develop new products are some of the factors the market is expected to boost in the forecast period. For instance, according to AVMA, there will be around 118,624 veterinarians present in the U.S. in 2020. Moreover, to achieve market share, Zoetis invests in R&D to develop new products. After acquiring Bayer in August 2020, Elanco strengthened its market penetration. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.
Market Competitive Landscape
Major key players in the companion animal ear infection treatment market are Vetoquinol S.A, Elanco, Zoetis, Inc., Merck Animal Health, Vedco, Inc., Virbac Corporation, Bayer Animal Heath, Dechra Pharmaceuticals plc, Ceva Santé Animale and Penn Veterinary Supply, Inc.
Vetoquinol S.A:
Overview:
Vetoquinol SA is based in France that works in the healthcare industry. The company specializes in anti-infectives, anti-pain inflammatories, cardiology, nephrology research, development, manufacture, marketing, and sale of veterinary pharmaceuticals and goods. Vetoquinol serves customers worldwide.
Product Portfolio:
Clavaseptin: It is a palatable antibiotic tablet used in dogs and cats, an antibiotic containing a combination of amoxicillin and a beta-lactomase inhibitor (which overcomes bacteria which are penicillin resistant). In dogs it is mainly used for dental infections, and in cats for skin infections.
